Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

- Thomas, Dennis, McDonald, Vanessa M., Gillman, Andrew, Hew, Mark, Hodge, Sandra, James, Alan, Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory P., Langton, David, Lee, Joy, Marks, Guy, Stevens, Sean, Peters, Matthew, Radhakrishna, Naghmeh, Reynolds, Paul N., Rimmer, Janet, Sivakumaran, Pathmanathan, Upham, John W., Wark, Peter, Yang, Ian A., Gibson, Peter G., Harvey, Erin S., Baraket, Melissa, Bardin, Philip, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping

Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma

- Kritikos, Vicky, Harvey, Erin S., Thomas, Dennis, Gibson, Peter G., Australian Mepolizumab Registry Investigators,, Stevens, Sean, Katelaris, Constance H., Langton, David, Rimmer, Janet, Farah, Claude S., Gillman, Andrew, Hew, Mark, Radhakrishna, Naghmeh

Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity

- Vertigan, Anne E., Harvey, Erin S., Beyene, Tesfalidet, Van Buskirk, Joseph, Holliday, Elizabeth G., Bone, Sarah L., McDonald, Vanessa M., Horvat, Jay C., Murphy, Vanessa E., Jensen, Megan E., Morgan, Geoffrey G., Zosky, Graeme R., Peters, Matthew, Farah, Claude S., Jenkins, Christine R., Katelaris, Constance H., Harrington, John Harrington, Langton, David, Bardin, Philip, Katsoulotos, Gregory P., Gibson, Peter G., Chien, J, Bowden, JJ, Rimmer, J, Bell, R, Gibson, PG

‘Breathing Fire’: Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma

- Beyene, Tesfalidet, Harvey, Erin S., Murphy, Vanessa E., Holliday, Elizabeth G., Vertigan, Anne E., Peters, Matthew, Farah, Claude S., Jenkins, Christine R., Katelaris, Constance H., Harrington, John, Langton, David, Bardin, Philip, Van Buskirk, Joseph, Katsoulotos, Gregory P., Upham, JW, Chien, J, Bowden, JJ, Rimmer, J, Bell, R, Gibson, Peter G., McDonald, Vanessa M., Jensen, Megan E., Horvat, Jay C., Morgan, Geoffrey G., Zosky, Graeme R., Jegasothy, Edward, Hanigan, Ivan

Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry

- Thomas, Dennis, Harvey, Erin S., Bardin, Philip, Peters, Matthew, Reynolds, Paul N., Langton, David, Baraket, Melissa, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Farah, Claude S., McDonald, Vanessa M., Wark, Peter A. B., Gibson, Peter G., Katsoulotos, GP, Lee, J, Radhakrishna, N, Reddel, HK, Rimmer, J, Sivakumaran, P, Wark, PAB, Gibson, PG, Stevens, Sean, Upham, John W., Katelaris, Constance H., Kritikos, Vicky, Gillman, Andrew, Harrington, John, Hew, Mark

Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetings

- Maltby, Steven, McDonald, Vanessa M., Upham, John W., Bowler, Simon D., Chung, Li P., Denton, Eve J., Fingleton, James, Garrett, Jeffrey, Grainge, Christopher L., Hew, Mark, James, Alan L., Jenkins, Christine, Katsoulotos, Gregory, King, Gregory G., Langton, David, Marks, Guy B., Menzies-Gow, Andrew, Niven, Robert M., Peters, Matthew, Reddel, Helen K., Thien, Francis, Wark, Peter A. B., Gibson, Peter G.

Mepolizumab effectiveness and identification of super-responders in severe asthma

- Harvey, Erin S., Langton, David, Katelaris, Constance, Stevens, Sean, Farah, Claude S., Gillman, Andrew, Harrington, John, Hew, Mark, Kritikos, Vicky, Radhakrishna, Naghmeh, Bardin, Philip, Peters, Matthew, Reynolds, Paul N., Upham, John W., Baraket, Melissa, Bowler, Simon, Bowden, Jeffrey, Chien, Jimmy, Chung, Li Ping, Grainge, Christopher, Jenkins, Christine, McDonald, Vanessa M., Wark, Peter A. B., Gibson, Peter G.